FDA Meets to Review Painkiller Safety

The Food and Drug Administration holds three days of meetings to debate the safety of painkilling drugs. In some clinical studies, Cox-2 drugs, such as Vioxx and Celebrex, have been shown to increase the risk of heart attacks and strokes. The FDA event is an effort to determine whether all such inhibitors carry similar risks.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: